Who Owns MannKind Stock?
NASDAQ: MNKDHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 57.04%
- Held by insiders
- 1.47%
- Institutional holders
- 330
- Institutions 57.0%
- Insiders 1.5%
- Public and other 41.5%
Who owns MannKind stock?
Institutional investors own about 57.0% of MannKind's shares, spread across 330 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 1.47% of MNKD.
The largest institutional holders are Blackrock Inc. (9.99%), Rubric Capital Management LP (5.60%) and State Street Corporation (5.03%). Together, the top 10 institutions control 36.4% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their MNKD positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MNKD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 32.13M | 9.99% | +12.3% |
| Rubric Capital Management LP | 18.00M | 5.60% | +397.2% |
| State Street Corporation | 16.17M | 5.03% | -13.4% |
| Vanguard Capital Management LLC | 13.17M | 4.10% | +2.2% |
| Geode Capital Management, LLC | 7.95M | 2.47% | +5.9% |
| Wellington Management Group, LLP | 7.84M | 2.44% | +138.9% |
| Frazier Life Sciences Management, L.P. | 6.60M | 2.05% | +11.9% |
| Deep Track Capital, Lp | 6.00M | 1.87% | +100.0% |
| 180 Wealth Advisors, LLC | 4.96M | 1.54% | +15.6% |
| FMR, LLC | 4.10M | 1.28% | +17.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MNKD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 9.33M | 2.90% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 8.99M | 2.80% |
| iShares Trust-iShares Russell 2000 ETF | 7.87M | 2.45% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 4.48M | 1.39% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 3.53M | 1.10% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 3.36M | 1.05% |
| iShares Trust-iShares Russell 2000 Growth ETF | 2.86M | 0.89% |
| iShares Trust-iShares Biotechnology ETF | 2.22M | 0.69% |
| Janus Detroit Street TRT-Janus Henderson Small/Mid Cap Growth Alpha ET | 1.68M | 0.52% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 1.57M | 0.49% |
Frequently asked questions
Who is the largest shareholder of MannKind?
Blackrock Inc. is the largest institutional shareholder of MNKD, owning 9.99% of shares outstanding (32.13M shares) as of its latest 13F filing.
What percentage of MannKind is owned by institutions?
Institutions own about 57.0% of MNKD shares and 57.9% of the public float.
How much of MannKind do insiders own?
Insiders, such as officers and directors, own about 1.47% of MNKD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.